|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Eden Biodesign Selected by Omnio Healer AB for cGMP Production of Clinical Trial Product in Wound Healing and Anti-infection
8/6/2009 8:35:32 AM
LIVERPOOL, United Kingdom & RESEARCH TRIANGLE PARK, N.C., & UMEÅ, Sweden--(BUSINESS WIRE)--Eden Biodesign and Omnio Healer AB, a pioneer company that develops novel therapies for wound healing and anti-infection, today announced that they have entered into a partnership agreement. Based on a novel therapeutic concept for wound healing and anti-infection, Omnio Healer is developing drug candidates with potent pro-inflammatory functions, and under this new agreement, Eden Biodesign will provide process development and cGMP production services relating to Omnio Healer’s lead recombinant protein candidate. Indeed, the agreement with Eden Biodesign relates to the expression of proteins through mammalian cell culture for use against several clinical indications primarily focused on chronic eardrum wound studies.
|
|
|
|
|
|
|
|
|
|
|